TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ENOLEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ENOLEN

ST13

US500000097690771

Class

5, 10

Filing

97690771

Registration

7698248

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

02/18/2025

Classification

Registered

Trademark type

Word

Nice classes

5, 10

Filing date

11/23/2022

Registration date

02/18/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/18/2025

Last transaction

02/18/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/01/2024

First use in commerce

02/01/2024

Drawing code

4

Owner type

03

Owner location

San Carlos, CA

Examiner

GORAN, BRADLEY TAYLOR

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

A. T. (pessoa física)

Representatives

Jonathan Feuchtwang JONATHAN FEUCHTWANG, ESQ

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for delivery to solid organ tumors; implant subcutaneous drug delivery devices sold filled with pharmaceutical preparations for extended release of anti-androgen drugs directly to prostate tissue

Class 10

Medical device for treating cancer

Publications

History of USPTO decisions and trademark events.

40 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/18/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/23/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/23/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/02/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/02/2024

IUAF

USE AMENDMENT FILED

08/01/2024

EISU

TEAS STATEMENT OF USE RECEIVED

08/01/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/30/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/04/2024

PUBO

PUBLISHED FOR OPPOSITION

06/04/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/15/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/30/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/05/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/04/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/04/2024

RDX3

NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED

04/02/2024

RDX1

ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED

04/02/2024

RRDX

ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED

04/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/06/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/06/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/06/2024

RDX3

NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED

03/06/2024

RDX1

ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED

03/06/2024

RRDX

ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED

03/06/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/05/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/05/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/05/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

02/16/2024

GNFR

FINAL REFUSAL E-MAILED

02/16/2024

CNFR

FINAL REFUSAL WRITTEN

02/16/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/13/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/12/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/12/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/08/2023

GNRT

NON-FINAL ACTION E-MAILED

09/08/2023

CNRT

NON-FINAL ACTION WRITTEN

09/08/2023

DOCK

ASSIGNED TO EXAMINER

09/05/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/28/2022

NWAP

NEW APPLICATION ENTERED

11/26/2022

Continuous trademark protection

Get notified about every new filing that threatens ENOLEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.